PHARMA NORD EXPORT ApS: Financial statements 2016
CVR: 70996510
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 2,239,595 and a net result of DKK 2,739,796 compared with DKK 3,155,255 the year before. That is a decrease of 1.1% compared with the year before. Equity in the 2016 report amounted to DKK 62,025,085. The solvency ratio was 80.3%.
- Gross Profit
- DKK 2,239,595
- Profit/Loss
- DKK 2,739,796
- Equity
- DKK 62,025,085
- Total Assets
- DKK 77,245,808
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 2.2 mio. | 2.7 mio. | 62 mio. | - |
| 2015 | - | 2.3 mio. | 3.2 mio. | 59.3 mio. | - |
| 2014 | - | 1.9 mio. | 3.1 mio. | 56.1 mio. | - |
| 2013 | - | 2.3 mio. | 6.3 mio. | 53 mio. | - |
| 2012 | - | 2.3 mio. | 6 mio. | 47.1 mio. | - |
Official annual report
Find more companies like PHARMA NORD EXPORT ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PHARMA NORD EXPORT ApS has published its annual report for 2015. Gross profit came to DKK 2,264,422, and the net result was DKK 3,155,255.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.